Little House Capital’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$612K Buy
3,140
+44
+1% +$9.12K 0.14% 103
2026
Q1
$695K Buy
+3,096
New +$772K 0.18% 99
2025
Q2
– Sell
-3,299
Closed -$739K – 134
2025
Q1
$739K Buy
+3,299
New +$770K 0.2% 97
2019
Q2
– Sell
-90
Closed -$9K – 235
2019
Q1
$9K Buy
+90
New +$9.29K 0.01% 252

Other funds holding RMD

Little House Capital's RMD Position: Q2 2026 in Review

Little House Capital increased its ResMed (RMD) stake by 1.4% in Q2 2026, buying an estimated $9.12K and bringing the position to 3,140 shares worth $612K. The position accounts for 0.14% of the portfolio, ranked #103.

Little House Capital first reported a position in RMD in Q1 2019 and has held it in 4 quarters since. The position peaked at $739K in Q1 2025. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Little House Capital held 3,140 shares of ResMed worth $612K as of Q2 2026.
  • Little House Capital bought 44 ResMed shares in Q2 2026, an estimated $9.12K.
  • ResMed made up 0.14% of Little House Capital's portfolio in Q2 2026, its #103 holding.
  • Little House Capital first reported a position in ResMed in Q1 2019 and has held it in 4 quarters since.
  • Little House Capital's ResMed position peaked at $739K in Q1 2025.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Little House Capital's 13F filing for Q2 2026, filed 7 Aug 2026.